In separate but related research, his lab found an Alzheimer’s drug candidate called J147 that also removes amyloid beta from nerve cells and reduces the inflammatory response in both nerve cells and the brain. It was the study of J147 that led the scientists to discover that endocannabinoids are involved in the removal of amyloid beta and the reduction of inflammation.
“Yes,” the Admiral answered.
。业内人士推荐立即前往 WhatsApp 網頁版作为进阶阅读
ITmedia �r�W�l�X�I�����C���ҏW�������삷���������[���}�K�W���ł�
WATCH: Jefferies' Brent Thill talks to CNBC ahead of Oracle earnings